Tens of thousands of Americans will soon be forced by their heath insurance to switch from one popular obesity drug to another that produces less weight loss. It is the latest example of the consequences of secret deals between drugmakers and middlemen, known as pharmacy benefit managers, that are hired by employers to oversee prescription coverage for Americans. Employers pay …
Read More »
Novo Nordisk will cut the price of its blockbuster weight loss medication Wegovy to $499 per month for certain patients who pay using their own money instead of going through insurance, the drug maker said on Wednesday. The move could cause more patients to start taking the drug. But the impact stands to be limited, because the decision does not …
Read More »
Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, capped off a somewhat turbulent 2024, reporting profit and revenue on Wednesday that comfortably beat Wall Street expectations. But the drugmaker said it expected sales growth to slow in 2025, as competition increases. Novo Nordisk retains its title as Europe’s most valuable company, but its share price has dropped about …
Read More »
That would slow the growth of the government’s spending on obesity drugs even as more people on Medicare started using them. New prices for the 10 drugs in the first round of price negotiations were announced last summer. Those prices will go into effect next year. Drugmakers were relieved that those cuts were not deeper. They have sued, unsuccessfully, to …
Read More »
When Stephane Castel first met with a group of Māori people and other Pacific Islanders in New Zealand to talk about his drug company’s plans for genetic research, locals worried he might be seeking to profit from the genes of community members without much thought to them. Instead, Dr. Castel and his colleagues explained, they were aiming to strike an …
Read More »
Unews World